Logo

American Heart Association

  49
  0


Final ID:

Fabry and HCM

  • Massera, Daniele  ( NYU Langone , NYC , New York , United States )
  • Author Disclosures:
    Daniele Massera: DO have relevant financial relationships ; Consultant:Cytokinetics:Past (completed) ; Consultant:Tenaya Therapeutics:Past (completed) ; Consultant:Rocket Pharmaceuticals:Active (exists now) ; Consultant:Sanofi:Active (exists now) ; Consultant:Chiesi Pharmaceuticals:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Managing Double Trouble, How the Experts Approach Complex Cases

Friday, 11/07/2025 , 04:45PM - 05:45PM

Cardiovascular Seminar

More abstracts on this topic:
More abstracts from these authors:
A Hypertrophic Cardiomyopathy-Based Model Estimate of the Prevalence of Danon Disease in the United States

Maron Martin, Massera Daniele, Manganaro Susan, Bailey Miranda, Rehbein Fletcher, Taylor Matthew

Case 3: Myocardial bridge in hypertrophic cardiomyopathy

Massera Daniele, Fearon William, Tremmel Jennifer

You have to be authorized to contact abstract author. Please, Login
Not Available